CeriBell Net Income Over Time
| CBLL Stock | 20.61 0.18 0.88% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out CeriBell Performance and CeriBell Correlation. Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CeriBell. Projected growth potential of CeriBell fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive CeriBell assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (3.67) | Revenue Per Share | Quarterly Revenue Growth 0.314 | Return On Assets | Return On Equity |
The market value of CeriBell is measured differently than its book value, which is the value of CeriBell that is recorded on the company's balance sheet. Investors also form their own opinion of CeriBell's value that differs from its market value or its book value, called intrinsic value, which is CeriBell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CeriBell's market value can be influenced by many factors that don't directly affect CeriBell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between CeriBell's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CeriBell should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, CeriBell's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cross Equities Net Income Analysis
Compare CeriBell and related stocks such as Treace Medical Concepts, Orthopediatrics Corp, and Standard Biotools Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TMCI | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (3.7 M) | (20.6 M) | (42.8 M) | (49.5 M) | (55.7 M) | (50.2 M) | (47.7 M) |
| KIDS | (9.5 M) | (9.5 M) | (9.5 M) | (9.5 M) | (9.5 M) | (7.9 M) | (6.6 M) | (8.9 M) | (12 M) | (13.7 M) | (32.9 M) | (16.3 M) | 1.3 M | (21 M) | (37.8 M) | (34 M) | (32.3 M) |
| LAB | (23.6 M) | (22.5 M) | (19 M) | (15.8 M) | (52.8 M) | (53.3 M) | (76 M) | (60.5 M) | (59 M) | (64.8 M) | (53 M) | (59.2 M) | (190.1 M) | (74.7 M) | (138.9 M) | (125 M) | (118.7 M) |
| EHAB | 24 M | 24 M | 24 M | 24 M | 24 M | 24 M | 24 M | 24 M | 24 M | 24 M | 75 M | 111.1 M | (40.4 M) | (80.5 M) | (156.2 M) | (140.6 M) | (133.6 M) |
| QSI | (35.8 M) | (35.8 M) | (35.8 M) | (35.8 M) | (35.8 M) | (35.8 M) | (35.8 M) | (35.8 M) | (35.8 M) | (35.8 M) | (36.6 M) | (95 M) | (132.4 M) | (96 M) | (101 M) | (90.9 M) | (95.5 M) |
| VREX | 109.6 M | 109.6 M | 109.6 M | 110.1 M | 80 M | 68.5 M | 51.6 M | 27.5 M | 15.5 M | (57.9 M) | 17.4 M | 30.3 M | 48.2 M | (47.7 M) | (69.9 M) | (62.9 M) | (59.8 M) |
| BFLY | (50.8 M) | (50.8 M) | (50.8 M) | (50.8 M) | (50.8 M) | (50.8 M) | (50.8 M) | (50.8 M) | (50.8 M) | (99.6 M) | (162.7 M) | (32.4 M) | (168.7 M) | (133.7 M) | (72.5 M) | (65.2 M) | (68.5 M) |
| AUTL | (31.1 M) | (31.1 M) | (31.1 M) | (31.1 M) | (31.1 M) | (7.5 M) | (12.6 M) | (19.7 M) | (31.1 M) | (123.8 M) | (142.1 M) | (142.1 M) | (148.8 M) | (208.4 M) | (220.7 M) | (198.6 M) | (188.7 M) |
CeriBell and related stocks such as Treace Medical Concepts, Orthopediatrics Corp, and Standard Biotools Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in CeriBell financial statement analysis. It represents the amount of money remaining after all of CeriBell operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| CeriBell | CBLL |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 360 North Pastoria |
| Exchange | NASDAQ Exchange |
null 20.61
Check out CeriBell Performance and CeriBell Correlation. For more information on how to buy CeriBell Stock please use our How to buy in CeriBell Stock guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
CeriBell technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.